John Glenn - Jun 20, 2022 Form 4/A - Amendment Insider Report for IRADIMED CORP (IRMD)

Role
Chief Financial Officer
Signature
/s/ John Glenn
Stock symbol
IRMD
Transactions as of
Jun 20, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/8/2022, 05:01 PM
Date Of Original Report
Jun 23, 2022
Previous filing
Mar 28, 2022
Next filing
Dec 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Award $0 +23.2K $0.00 23.2K Jun 20, 2022 Common Stock 23.2K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
F2 The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3 This Form 4/A is being filed solely to correct administrative errors in (i) the number of shares of Common Stock underlying Restricted Stock Units shown as acquired and beneficially held by the reporting person and (ii) the vesting commencement date of such Restricted Stock Units in his Form 4 filed on June 23, 2022 (the "Original Form 4"). All other information set forth in the Original Form 4 remains correct.